| Active substance |
Sildenafil |
| Also known as |
Viagra, Revatio |
| Blood pressure |
Can cause transient decreases in blood pressure |
| Chemical name |
1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine citrate |
| Dosage (medical) |
Commonly 50 mg, adjustable between 25 mg to 100 mg depending on efficacy and tolerance |
| Dosage (sports) |
Not typically used in sports for performance enhancement |
| Effects |
Improves erectile response when a man is sexually stimulated |
| Formula |
C28H38N6O11S |
| Half-life |
Approximately 4 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Detection in blood tests for substances |
| Main action |
Enhances erectile function by increasing blood flow to the penis |
| Side effects |
Headache, flushing, dyspepsia, nasal congestion, impaired vision, photophobia, and blurred vision |
| Storage conditions |
Store at room temperature between 15-30В°C (59-86В°F) in a closed container |
| Substance class |
Phosphodiesterase type 5 (PDE5) inhibitor |
| Trade name |
Viagra |
| Use in sports |
Not recognized for performance enhancement in sports |
| Water Retention |
None |
| Manufacturer |
Aavishkaar Oral Strips Pvt. Ltd |
